These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 34620056)

  • 1. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
    Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
    Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment.
    Shi J; Wang Y; Cheng L; Wang J; Raghavan V
    Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
    Peterson CT
    J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.
    Satokari R
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome.
    Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H
    Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
    Panebianco C; Andriulli A; Pazienza V
    Microbiome; 2018 May; 6(1):92. PubMed ID: 29789015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
    Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Microbiome: Is it Still Beneficial?
    Elfarargy MS; Elbadry DH; Ahmad AR; Elhady HA
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):617-625. PubMed ID: 37916638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
    Chou YT; Kan WC; Shiao CC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.